<ѻý>Sensitivity Heightened with Chronic Low Back Painѻý> Catastrophizing is also a common feature Mar 07, 2018
<ѻý>Death Strikes Young in RAѻý> Most common causes were circulatory, respiratory, and malignancy Mar 07, 2018
<ѻý>Native Americans Face Challenges in Lupusѻý> Disease onset is earlier, clinical pattern differs, and disparities exist in treatment Mar 02, 2018
<ѻý>One Gout Medication Comes Out on Top for CV Riskѻý> Allopurinol the loser in retrospective comparison of two drugs Feb 26, 2018
<ѻý>Cancer Risk Stable in Kids on Anti-TNFsѻý> But background risks higher than in the general population Feb 20, 2018
<ѻý>Q&A: Avindra Nath, MDѻý> Leading NIH study of post-infection chronic fatigue syndrome Feb 19, 2018
<ѻý>Pearls From: David Rubin, MDѻý> Expert discusses how to treat C. diff in IBD patients Dec 26, 2017 video
<ѻý>Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trialѻý> Risankizumab broadly effective against joint and skin symptoms Nov 09, 2017
<ѻý>PsA Structural Damage Inhibited with Secukinumabѻý> Loading dose appears to improve outcomes, researchers say Nov 09, 2017
<ѻý>Novel Drug Promising for IgG4-Related Diseaseѻý> 8 of 15 patients achieved remission in phase II study Nov 08, 2017
<ѻý>Prospects Good for Ustekinumab Gaining SLE Indicationѻý> Positive phase II data reported in ACR late-breaker Nov 08, 2017
<ѻý>ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologicsѻý> Selections from late-breaker poster presentations at rheumatology meeting Nov 08, 2017
<ѻý>Mixed Results in Studies of Biosimilar-Originator Switchingѻý> Is there a nocebo effect in changing between drugs supposed to be equal? Nov 08, 2017
<ѻý>Biologics During Pregnancy Don't Raise Infection Risk for Infantsѻý> Gestational timing of exposure to biologic not an issue Nov 07, 2017
<ѻý>Tool Available to Help Rheumatologists Cope with MIPSѻý> Eases reporting needed to avoid penalties, earn incentive payments under MACRA Nov 07, 2017
<ѻý>Lipid Changes with Sirukumab Called 'Anti-Atherogenic'ѻý> Looking for silver-lining in cloudy trial data Nov 06, 2017
<ѻý>Bruton's Tyrosine Kinase Marches on as Rheumatology Targetѻý> Industry remains interested despite lackluster phase II results with Celgene drug Nov 06, 2017
<ѻý>Injecting Arthritic Knees Carries Sepsis Riskѻý> Study identified four risk factors for sepsis after injections for knee pain. Nov 06, 2017
<ѻý>In RA Patients, 2-Week Methotrexate Holiday Boosts Flu Vax Efficacyѻý> Pragmatic trial shows 15%-20% bump in antibody titers Nov 05, 2017
<ѻý>ACR 2017: Biosimilar Debate, Inflammation in OA, and Moreѻý> Special lecture will look back at TNF as rheumatology drug target Nov 03, 2017
<ѻý>Can Safe Injection Sites Calm the Opioid Crisis?ѻý> Critics, proponents battle over decades-old issue Aug 21, 2017
<ѻý>Helping Kids with Chronic Diseases Move to Adult Careѻý> Program at Wisconsin hospital develops self-management skills Aug 13, 2017
<ѻý>Does Fibromyalgia Mask Spondyloarthritis?ѻý> A new study sheds some light on this relationship Jun 23, 2017
<ѻý>Tofacitinib Shows MRI Benefits in ASѻý> Improvements seen on MRI for both sacroiliac joints and spine Jun 16, 2017
<ѻý>Remission Common in Early SpA With Golimumabѻý> Drug-free remission maintained for more than half after at least 12 months Jun 15, 2017
<ѻý>Moderate Alcohol Intake OK for RA Patients on Methotrexateѻý> Patients on higher doses of meds may still need to abstain May 30, 2017
<ѻý>Mortality Still High in Vasculitisѻý> Risk 2.7-fold higher than in the general population, meta-analysis showed May 07, 2017
<ѻý>Are Statins Behind Some Back Problems?ѻý> Claims data suggest association, but cardiologists urge caution May 01, 2017
<ѻý>Multiple Metabolic Abnormalities Seen in Lupusѻý> Targeting insulin resistance alone won't be enough Apr 04, 2017
<ѻý>Pre-TKA Opioid Script Predicts Post-Op Prescriptionѻý> Especially prevalent after 6 months post-op Mar 20, 2017
<ѻý>RA Drug Active in Psoriatic Arthritisѻý> Multiple endpoints improved with tofacitinib Mar 07, 2017
<ѻý>Cimzia Passes Muster in Two Psoriasis Trialsѻý> Met primary efficacy goals versus placebo; third trial still to come Mar 06, 2017
<ѻý>A Rocky Start for Biosimilar Inflectra?ѻý> Infliximab biosimilar approved, but obstacles remain Dec 27, 2016
<ѻý>Knee OA No Excuse to Skip Out on Physical Activityѻý> Patients met thresholds for sit-to-stand, gait speed, and walking speed Nov 21, 2016
<ѻý>Lowering Urate Helps Renal Functionѻý> Most improvement seen in stage 3 chronic kidney disease Nov 18, 2016
<ѻý>Pro Soccer Career: A Risk Factor for Osteoarthritis in Menѻý> Study also suggests controversial joint injections hike OA risk Nov 16, 2016
<ѻý>Reassuring Cancer Data With JIA Txѻý> No apparent increase in risk with anti-TNF treatment Nov 16, 2016
<ѻý>Two RA Agents Similar in Head-to-Head Trialѻý> Sponsor's hopes of proving Cimzia's superiority to Humira dashed Nov 16, 2016
<ѻý>ACR: Actemra Found Steroid-Sparing in GCAѻý> The era of unending steroid treatment is over Nov 15, 2016